Latest Magazines

In this issue, we hear from Victoria Gray, the first person to receive a CRISPR cell-based gene therapy for sickle cell disease (SCD). She shares her experiences of the life-changing therapy and talks about the struggles faced by SCD patients and the broader implications of gene therapy accessibility.

In our feature article, we ask leading scientists for their insights on major advancing fields, from cell and gene therapies to psychedelics. Discover the technologies and techniques propelling these areas forward and explore the potential challenges researchers may face.

In this issue of The Scientific Observer, we’re focusing on synthetic biology – a field that fuses biology and engineering to produce biological systems with novel abilities. Find out how nature’s tools – when redesigned – can support humanity’s efforts to develop therapeutics, combat global issues such as climate change and much more.

In issue 31, we’re exploring the expanding realm of oncology. From the use of AI in cancer studies, to a story of tragic loss that inspired one scientist’s quest to find a cure, we’re uncovering the latest advances in cancer research and more.

In issue 30 of The Scientific Observer, we’re taking a deep dive into topical issues faced by science and society, from food sustainability and climate change, issues of ethics and integrity in the sharing of scientific research to vaccine mandates.

Issue 29 explores the power of the placebo in psychedelic trials, asking leading experts why this phenomenon occurs and what it means for the future of these drugs in clinical practice.

Issue 26 highlights:
Neurodegeneration: Are We Closer to a Cure, or Still a World Apart?
Time To Say Goodbye to the Traditional BMI
A Recipe for Richer Metabolomics

With 90% of novel drug candidates never reaching the clinic, the need for new and effective therapeutics has never been more pressing. This month’s feature article discusses how rapid developments in AI and automation platforms provide new tools for probing the complexities of biology and accelerating drug development.

This month, we’re confronting the growing popularity of ChatGPT and its potential impact on the foundations of science, asking – is it really the end of the world as we know it?

In this issue, we embark on an investigative journey into the world of “predatory conferences”, and discuss how DNA sequencing can uncover the impact of colonialism and oppression on Native populations. This, and much more, in issue 22 of The Scientific Observer.